These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35220567)

  • 21. Delivery of therapeutic agents and cells to pancreatic islets: Towards a new era in the treatment of diabetes.
    Zeynaloo E; Stone LD; Dikici E; Ricordi C; Deo SK; Bachas LG; Daunert S; Lanzoni G
    Mol Aspects Med; 2022 Feb; 83():101063. PubMed ID: 34961627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA-regulated pathways in pancreatic β cells: Their role in diabetes.
    González-Moro I; Santin I
    Int Rev Cell Mol Biol; 2021; 359():325-355. PubMed ID: 33832652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An accomplice more than a mere victim: The impact of β-cell ER stress on type 1 diabetes pathogenesis.
    Sahin GS; Lee H; Engin F
    Mol Metab; 2021 Dec; 54():101365. PubMed ID: 34728341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D supplementation induces CatG-mediated CD4
    Lai X; Liu X; Cai X; Zou F
    Am J Physiol Endocrinol Metab; 2022 Jan; 322(1):E74-E84. PubMed ID: 34779254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic modulation of β cells by interferon-α via PNPT1/mir-26a/TET2 triggers autoimmune diabetes.
    Stefan-Lifshitz M; Karakose E; Cui L; Ettela A; Yi Z; Zhang W; Tomer Y
    JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30721151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes.
    Jalili RB; Zhang Y; Hosseini-Tabatabaei A; Kilani RT; Khosravi Maharlooei M; Li Y; Salimi Elizei S; Warnock GL; Ghahary A
    PLoS One; 2016; 11(1):e0146970. PubMed ID: 26765526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNAs as novel biomarkers for Type 2 diabetes.
    Zhu H; Bian X; Gong J; Yu P; Lu H
    Biomark Med; 2020 Oct; 14(15):1501-1511. PubMed ID: 33155821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-inflammatory therapy in type 1 diabetes.
    Baumann B; Salem HH; Boehm BO
    Curr Diab Rep; 2012 Oct; 12(5):499-509. PubMed ID: 22791179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A long non-coding RNA that harbors a SNP associated with type 2 diabetes regulates the expression of
    González-Moro I; Rojas-Márquez H; Sebastian-delaCruz M; Mentxaka-Salgado J; Olazagoitia-Garmendia A; Mendoza LM; Lluch A; Fantuzzi F; Lambert C; Ares Blanco J; Marselli L; Marchetti P; Cnop M; Delgado E; Fernández-Real JM; Ortega FJ; Castellanos-Rubio A; Santin I
    Front Endocrinol (Lausanne); 2023; 14():1101934. PubMed ID: 36824360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo islet protection by a nuclear import inhibitor in a mouse model of type 1 diabetes.
    Moore DJ; Zienkiewicz J; Kendall PL; Liu D; Liu X; Veach RA; Collins RD; Hawiger J
    PLoS One; 2010 Oct; 5(10):e13235. PubMed ID: 20949090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Islet Long Noncoding RNAs: A Playbook for Discovery and Characterization.
    Singer RA; Sussel L
    Diabetes; 2018 Aug; 67(8):1461-1470. PubMed ID: 29937433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Map of Human Type 1 Diabetes Progression by Imaging Mass Cytometry.
    Damond N; Engler S; Zanotelli VRT; Schapiro D; Wasserfall CH; Kusmartseva I; Nick HS; Thorel F; Herrera PL; Atkinson MA; Bodenmiller B
    Cell Metab; 2019 Mar; 29(3):755-768.e5. PubMed ID: 30713109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential role of type I interferon in the pathogenic process leading to type 1 diabetes.
    Qaisar N; Jurczyk A; Wang JP
    Curr Opin Endocrinol Diabetes Obes; 2018 Apr; 25(2):94-100. PubMed ID: 29369915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
    Fändrich F; Ungefroren H
    Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular Vesicles in Immune System Regulation and Type 1 Diabetes: Cell-to-Cell Communication Mediators, Disease Biomarkers, and Promising Therapeutic Tools.
    Grieco GE; Fignani D; Formichi C; Nigi L; Licata G; Maccora C; Brusco N; Sebastiani G; Dotta F
    Front Immunol; 2021; 12():682948. PubMed ID: 34177928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of Type 1 Diabetes may occur through a Type 2 Diabetes mechanism.
    Josefsen K; Krogvold L; Gerling IC; Pociot F; Dahl-Jørgensen K; Buschard K
    Front Endocrinol (Lausanne); 2022; 13():1032822. PubMed ID: 36589856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic regulation of RNA splicing in human pancreatic islets.
    Atla G; Bonàs-Guarch S; Cuenca-Ardura M; Beucher A; Crouch DJM; Garcia-Hurtado J; Moran I; ; Irimia M; Prasad RB; Gloyn AL; Marselli L; Suleiman M; Berney T; de Koning EJP; Kerr-Conte J; Pattou F; Todd JA; Piemonti L; Ferrer J
    Genome Biol; 2022 Sep; 23(1):196. PubMed ID: 36109769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNAs in type 1 diabetes: new research progress and potential directions.
    Miao C; Chang J; Zhang G; Fang Y
    Biochem Cell Biol; 2018 Oct; 96(5):498-506. PubMed ID: 29554441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of long non-coding RNAs in the regulation of pancreatic beta cell identity.
    Wilson ME; Pullen TJ
    Biochem Soc Trans; 2021 Nov; 49(5):2153-2161. PubMed ID: 34581756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The genetic and regulatory architecture of ERBB3-type 1 diabetes susceptibility locus.
    Kaur S; Mirza AH; Brorsson CA; Fløyel T; Størling J; Mortensen HB; Pociot F;
    Mol Cell Endocrinol; 2016 Jan; 419():83-91. PubMed ID: 26450151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.